Dr. Azar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114Phone+1 800-711-4644Fax+1 617-724-6801
Summary
- Dr. Sharl Azar is a hematologist in Boston, MA at the Massachusetts General Hospital and Harvard Medical School where he serves as the Director of the Comprehensive Sickle Cell Disease Treatment Center and the inaugural Robert K. Kraft Chair in Diversity, Equity, and Inclusion. He received his medical degree from Oregon Health and Science University School of Medicine where he also completed his residency and fellowship before completing a second fellowship in hemostasis and thrombosis at the University of California, San Diego.
Education & Training
- University of California, San DiegoHemostasis & Thrombosis, 2018 - 2020
- Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 2013 - 2016
- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2010 - 2013
- Oregon Health and Science University School of MedicineClass of 2010
Certifications & Licensure
- OR State Medical License 2015 - Present
- MA State Medical License 2020 - 2026
- CA State Medical License 2018 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 2 citationsRacial and Ethnic Disparities in Metabolic Bone Disease.Lauren Y Maldonado, Linette Bosques, Sara J Cromer, Sharl S Azar, Elaine W Yu
Endocrinology and Metabolism Clinics of North America. 2023-12-01 - Case 37-2023: A 29-Year-Old Man with Sickle Cell Disease and Right Hip Pain.Sharl S Azar, F Joseph Simeone, Jana Jarolimova, E Zachary Nussbaum
The New England Journal of Medicine. 2023-11-30 - 9 citationsManagement of severe factor XI deficiency in cardiac surgery: A case report and review of the literature.Sharl Azar, Ophira Salomon, Jason A. Taylor
Haemophilia. 2017-08-31
Press Mentions
- Patient Dies in Beam Trial of SCD Candidate; Company Cites ConditioningNovember 5th, 2024
- Expert Answers Questions About Sickle Cell DiseaseSeptember 28th, 2024
- Dr. Mallika Marshall Explains Importance of Black Blood Donors for Patients with Sickle Cell DiseaseFebruary 24th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: